US2012101006A1PendingUtilityA1
Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs
Est. expiryApr 19, 2021(expired)· nominal 20-yr term from priority
Inventors:Peter G. SchultzLei WangJohn Christopher AndersonJason W. ChinDavid R. LiuThomas J. MaglieryEric MeggersRyan A. MehlMiro PastrnakStephen SantoroZhiwen Zhang
A61P 43/00A61P 7/00C12P 13/00C07K 14/505C12P 21/02C12P 13/04C12N 9/93C12N 15/67C12P 13/22C07K 14/00C12P 19/26C12P 21/00C12P 13/005
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides compositions and methods for generating components of protein biosynthetic machinery including orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNAs/synthetases. Methods for identifying orthogonal pairs are also provided. These components can be used to incorporate unnatural amino acids into proteins in vivo.
Claims
exact text as granted — not AI-modified1 .- 114 . (canceled)
102 . A method for identifying an orthogonal tRNA-tRNA synthetase pair for use in an in vivo translation system of a second organism, the method comprising:
introducing a marker gene, a tRNA and an aminoacyl-tRNA synthetase (RS) isolated or derived from a first organism into a first set of cells from the second organism; introducing the marker gene and the tRNA into a duplicate cell set from the second organism; and selecting or screening for surviving cells or for cells showing a specific screening response in the first set that fail to survive or show said response in the duplicate cell set, wherein the first set and the duplicate cell set are grown in the presence of a selection or screening agent, wherein the surviving or screened cells comprise the orthogonal tRNA-tRNA synthetase pair for use in the in the in vivo translation system of the second organism.
103 . The method of claim 102 , wherein the comparing and selecting or screening comprises an in vivo complementation assay.
104 . The method of claim 102 , wherein concentration of the selection or screening agent is varied.
105 . The method of claim 102 , wherein the first organism is a prokaryotic organism.
106 . The method of claim 102 , wherein the second organism is a prokaryotic organism.
107 . The method of claim 102 , wherein the first and second organism are different.
108 . The method of claim 102 , wherein the first organism is selected from the group consisting of: Methanococcus jannaschii, Methanobacterium thermoautotrophicum , and a Halobacterium.
109 . The method of claim 102 , wherein the second organism is Escherichia coli.
110 . The method of claim 102 , wherein the selecting or screening comprises one or more positive or negative selection or screening chosen from the groups consisting of: a change in amino acid permeability, a change in translation efficiency, and a change in translational fidelity, and wherein the one or more change is based upon a mutation in one or more gene in an organism in which an orthogonal tRNA-tRNA synthetase pair are used to produce protein.
111 . The method of claim 102 , wherein the selecting or screening comprises selecting or screening at least 2 selector codons within one or more selection gene or within one or more screening gene.
112 . The method of claim 111 , wherein the at least 2 selector codons are in the same selection gene or the same screening gene.
113 . The method of claim 111 , wherein the at least 2 selector codons are in different selection or screening genes.
114 . The method of claim 111 , wherein the at least 2 selector codons comprise different selector codons.
115 . The method of claim 111 , wherein the at least 2 selector codons comprise the same selector codons.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.